Lisa Blunt Rochester (DE-at-large D+6), an “emerging player” in healthcare policy, does not support Jayapal’s M4A legislation — nor does she support the Green New Deal or military budget cuts, despite being in the Congressional Progressive Caucus.

By Christopher D. Cook, RootsAction

Lisa Blunt Rochester has served as Delaware’s lone congresswoman since 2017, after filling the seat vacated by Democratic Gov. John Carney; she made history as the first African-American and first woman elected to Congress from Delaware. While Delaware is a blue state (D+6, choosing Biden by 58 percent in 2020), Blunt Rochester has consistently been one of the most conservative members of the Congressional Progressive Caucus.

Lisa Blunt Rochester (DE-at-large. D+6): 80 percent disagreement.Heralded as an “emerging player” in congressional healthcare policy, Blunt Rochester has not supported Jayapal’s Medicare for All legislation. Notably, Blue Cross/Blue Shield is among her top campaign contributors this cycle. In 2018, the insurance industry sector was Blunt Rochester’s top campaign funder, donating $105,226.

Blunt Rochester also failed to support either Green New Deal measure, and did not back the COVID-vaccine TRIPS waiver push. In 2020 and 2021, Blunt Rochester voted against 10 percent “defense” budget cuts, while voting for military spending hikes. She also voted last year to reauthorize government surveillance powers, and voted to expand those powers in 2018. According to the Open Secrets website, she receives substantial campaign donations from “defense/aerospace,” pharmaceuticals, “pro-Israel,” and oil and gas sectors.

Lisa Blunt Rochester (DE-at-large. D+6): 80 percent disagreement.

Strikingly, Blunt Rochester was one of only two Progressive Caucus members who voted with Republicans in 2018 to weaken banking regulations in the Dodd-Frank Act, the Democrats’ fairly limited 2010 Wall Street reform law.

Read The Full Report